(Q34052830)

30 July 2017

1 reference

title

Bipolar disorder therapeutics: maintenance treatment (English)

1 reference

30 July 2017

1 reference

Sachs GS

1

1 reference

30 July 2017

Thase ME

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

30 July 2017

published in

Biological Psychiatry

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

573-581

1 reference

Antidepressant-induced mania and cycle acceleration: a controversy revisited

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Rapid cycling bipolar affective disorder. II. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Does lithium reduce the mortality of recurrent mood disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Lithium and recurrence in a long-term follow-up of bipolar affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Mood stabilizer combinations: a review of safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Long-term risperidone treatment in bipolar disorder: 6-month follow up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Course and outcome in bipolar affective disorder: a longitudinal follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Outcome in manic disorders. A naturalistic follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Bipolar depression: an underestimated treatment challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Lithium use and discontinuation in a health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Course of the Manic-Depressive Cycle and Changes Caused by Treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Depot antipsychotics in the prophylaxis of bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Carbamazepine vs lithium in the treatment and prophylaxis of mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Long-term outcome of lithium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

An evaluation of continuation therapy with tricyclic antidepressants in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Outcome of bipolar disorder on long-term treatment with lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Lithium prophylaxis of bipolar illness. The value of combination treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Treatment of mixed mania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Continuation drug therapy for major depressive episodes: how long should it be maintained?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Response to maintenance therapy in bipolar illness. Effect of index episode.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Lithium plus valproate as maintenance polypharmacy for patients with bipolar I disorder: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

The Use of Lithium in Affective Disorders, III: A Double-Blind Study of Prophylaxis in Bipolar Illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Discontinuation of maintenance treatment in bipolar disorder: risks and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

The effect of carbamazepine and lithium on remission from affective illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

A controlled evaluation of lithium prophylaxis in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

inferred from DOI database lookup

7 January 2021

based on heuristic

A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900991-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)00991-4

1 reference

30 July 2017

1 reference